![]() | GenomesDAO (GENE) |
GenomesDAO is a genomic data security company that democratizes and decentralizes genomics in Healthcare. Users make passive income on their DNA stored in AMD SEV-ES, vaults using DeFi Protocol governance and DAO membership is only achieved by staking GENE, the deflationary GenomesDAO utility token.
Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is GenomesDAO
Genomes.io is a genomic data security company co-founded by Dr Mark Hahnel and Aldo de Pape in 2018. We are a UK-registered company and operate from London, UK. The project strives to meet the increasing expectations of research organizations, institutions as well as customers for the security of genomic data and the quality of research workflow. In order to increase the democratization and decentralization of genomic studies, we focus on combining cutting-edge technologies such as AMD’s SEV, blockchain and decentralized finance.
GenomesDAO Roadmap
MISO Public $GENE Sale
NFT Project Launch
Company Operations
- Scale up Team
- Apply tokenomics across platform
10,000 Genomes is our AMD SEV-ES vaults
Brokerage of Data to pharma - aka - making passive income for our users
Launch of GenomesDAO secure Organisational Platform (Rare Disease Charities etc)
Expansion of Tests Available - Open API to 3rd Parties
Token Sale Dates
IDO
Token Allocation
Funding Details
Token distribution
30% - IDO
30% - Liquidity
6% - Pre Seed
5.66% - Folks who supported GenomesDAO over the last 3 years
8.34% - Marketing
10% - Team
10% - Locked
Project team












Advisors













